🟢 Azitra is trading 0.16% up in pre-market with no company-specific catalyst identified

Azitra is trading 0.16% up at $0.13, essentially unchanged from the August 19, 2026 close, with no new company-specific announcement, filing, earnings update, or other direct catalyst identified for August 20.

• The latest reported update remains the August 12, 2026 second-quarter release, covering clinical development and financial results.
• Biotech sentiment is stronger pre-market, with the sector ETF up 2.27%, but Azitra’s minimal move does not clearly confirm a sector-driven rally.